Highlights
Nature Index: How the US tech industry is shaping the transition to green energy
20 March 2025Major investments to fuel AI’s power demands are not the only way big tech is having an influence.
Engineering: Electric Vehicle Market Slowly Edges Toward Solid-State Batteries
03 March 2025Companies are gradually overcoming technical challenges with batteries that offer longer driving range and safer operation.
C&EN: ‘Berkelocene’ puts exotic berkelium in a sandwich
28 February 2025Researchers find bonding surprises at the extreme end of organometallic chemistry.
Nature: Can this revolutionary plastics-recycling plant help solve the pollution crisis?
04 February 2025A world-first facility has a new way to break down ‘unrecyclable’ plastic waste.
C&EN: Slow proteins may contribute to many chronic diseases
04 December 2024Reactive oxygen species in cells cause proteins to link up through disulfide bonds, reducing their mobility.
TESTIMONIALS
“As an editor and reporter, Mark Peplow is fast, accurate, and versatile. He covers science policy and pure research with equal passion, and his writing combines a scientist’s precision with a journalist’s verve.” Tim Appenzeller
Former Chief Magazine Editor at Nature, now News Editor at Science
"Mark guided me through some of the most challenging stories I've written. These are pieces I might not have attempted were it not for his steady editorial hand." Linda Nordling
Freelance Journalist, South Africa
“Working with Mark is never anything other than a pleasure. He is the kind of editor that writers hope for: able to identify what needs fixing and what doesn’t, bringing to bear a wealth of knowledge, always clear, prompt and easy to talk with. Much of that comes from being a splendid writer himself.”
Philip Ball
Freelance Science Writer
Category Archives: Highlights
The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The FDA has finally indicated it will approve the first biosimilar drug for the United States, years after Europe.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: FDA plays catch-up with Europe as it moves towards first biosimilar approval
The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
‘Bipolar androgen therapy’ helps patients with tumours that are resistant to conventional hormone treatments.
Posted in Highlights
Comments Off on The Pharmaceutical Journal: Testosterone rollercoaster tackles prostate cancer
Spectrum: Perovskite Solar Cell Bests Bugbears, Reaches Record Efficiency
Perovskite photovoltaic success story continues apace.
Posted in Highlights
Comments Off on Spectrum: Perovskite Solar Cell Bests Bugbears, Reaches Record Efficiency
Nature: Peer review — reviewed
Top medical journals filter out poor papers but often reject future citation champions.
Posted in Highlights
Comments Off on Nature: Peer review — reviewed
Chemistry World: A bad business
Targets and assessments can boost productivity at universities – but only if they do not stifle creativity and alienate the academic workforce.
Posted in Highlights
Comments Off on Chemistry World: A bad business
Chemical & Engineering News: Smartphone Microscope Sizes Up Single DNA Molecules
Lightweight phone attachment could lead to low-cost clinical tests in the developing world.
Posted in Highlights
Comments Off on Chemical & Engineering News: Smartphone Microscope Sizes Up Single DNA Molecules
Pharmaceutical Journal: Bacteria’s protein machinery may offer antibiotic target
Bacteria use a molecular ruler to ensure that the polysaccharides are the right length to offer protection.
Posted in Highlights
Comments Off on Pharmaceutical Journal: Bacteria’s protein machinery may offer antibiotic target
Chemistry World: It’s time to speak up for Europe
Researchers in the UK benefit enormously from their country’s membership of the EU. They need to say so.
Posted in Highlights
Comments Off on Chemistry World: It’s time to speak up for Europe
Scientific American: Centipede and Snake Venoms Form a Basis for New Pain Drugs
Venom molecules could provide alternatives to addictive opiate drugs.
Posted in Highlights
Comments Off on Scientific American: Centipede and Snake Venoms Form a Basis for New Pain Drugs
Nature: Twisted light sends Mozart image over record distance
Vienna demonstration shows that the technology can boost data capacity of laser beams over long distances.
Posted in Highlights
Comments Off on Nature: Twisted light sends Mozart image over record distance
